ARTICLE | Company News
Cambridge Biostability, Lipoxen, Health Protection Agency, University of Cambridge infectious news
October 5, 2009 7:00 AM UTC
In June, Cambridge Biostability entered voluntary liquidation. The company's assets included its VitRIS (Vitrified Readily Injectable Suspensions) technology to make thermostable liquid vaccines. As a...